MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$2.83 USD
-0.03 (-1.05%)
Updated Jul 18, 2024 03:21 PM ET
After-Market: $2.80 -0.03 (-1.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
MDXH 2.83 -0.03(-1.05%)
Will MDXH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MDXH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MDXH
Agiliti (AGTI) Q4 Earnings Beat Estimates
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
MDXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Beats Q3 Earnings Estimates
Surgery Partners (SGRY) Soars 9.9%: Is Further Upside Left in the Stock?
Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates
Other News for MDXH
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
MDxHealth files to sell 2.24M shares for holders
MDxHealth files to sell 2.24M ordinary shares for holders
Mdxhealth to Present at Upcoming Investor Conferences